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Abstract
Selenium is an essential trace element and selenoprotein N (SelN) was the first selenium-containing protein shown to be
directly involved in human inherited diseases. Mutations in the SEPN1 gene, encoding SelN, cause a group of muscular
disorders characterized by predominant affection of axial muscles. SelN has been shown to participate in calcium and redox
homeostasis, but its pathophysiological role in skeletal muscle remains largely unknown. To address SelN function in vivo,
we generated a Sepn1-null mouse model by gene targeting. The Sepn12/2 mice had normal growth and lifespan, and were
macroscopically indistinguishable from wild-type littermates. Only minor defects were observed in muscle morphology and
contractile properties in SelN-deficient mice in basal conditions. However, when subjected to challenging physical exercise
and stress conditions (forced swimming test), Sepn12/2 mice developed an obvious phenotype, characterized by limited
motility and body rigidity during the swimming session, as well as a progressive curvature of the spine and predominant
alteration of paravertebral muscles. This induced phenotype recapitulates the distribution of muscle involvement in patients
with SEPN1-Related Myopathy, hence positioning this new animal model as a valuable tool to dissect the role of SelN in
muscle function and to characterize the pathophysiological process.
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Introduction
Selenium is of fundamental importance to human and animal
health. Dietary restriction of this trace element pointed to its
implication in cancer prevention, viral infections protection,
fertility and aging [1,2]. The major biological form of selenium
is selenocysteine, the 21st amino acid, which is co-translationally
incorporated into a specific class of proteins (selenoproteins),
through a dedicated machinery [3]. The presence of this particular
amino acid in seleno-enzyme active sites confers an increased
catalytic reactivity due to the particular redox and nucleophilic
properties of the selenol group [4,5]. In addition to the above-
mentioned dysfunctions, it was shown that selenium deficiency,
sometimes associated with simultaneous lack of vitamin E, causes
different muscular pathologies (reviewed in[6,7]). Since 2001,
mutations in the human SEPN1 gene encoding selenoprotein N
(SelN) have been associated with four early-onset, autosomal
recessive neuromuscular disorders, now recognised to represent a
unique disease termed SEPN1-Related Myopathy (SEPN1-RM)
[8–11]; reviewed in [12]. This muscular disease is clinically
homogeneous, characterized by generalized muscle atrophy and
predominant weakness of neck and trunk muscles from infancy,
leading to severe scoliosis, spinal rigidity and life-threatening
respiratory insufficiency in childhood or adolescence, but con-
trasting with relatively unaffected limb strength and ambulation.
On the other hand, the histopathological presentation is
heterogeneous with most SEPN1-RM muscle biopsies showing
predominance and/or hypotrophy of type I fibers, as well as small
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focal areas of mitochondria depletion and sarcomere disorganiza-
tion (short core lesions or ‘‘minicores’’) within muscle fibers;
protein aggregates have been observed in some cases but are less
frequent, and necrosis/regeneration is mild or absent [12]. Many
SEPN1 mutations have been described so far, but no direct
phenotype-genotype correlation could be established [7,13–15].
This observation, together with the large morphological spectrum
of SEPN1-RM, suggests a complex underlying pathophysiological
mechanism.
Cellular and biochemical studies established that SelN is a trans-
membrane glycoprotein of 65-kDa located in the endoplasmic
reticulum. Examination of the amino acid sequence identified a
putative calcium binding EF-hand motif next to a membrane-
addressing signal peptide at the N-terminus, but no function could
be proposed based on sequence comparison or homology search
[16]. Recent experiments revealed physical and functional
interaction between SelN and the ryanodine receptor (RyR), a
calcium release channel of the sarcoplasmic reticulum [17]. In
zebrafish embryos or patient muscles depleted in SelN, RyR
displayed reduced activity and abnormal sensitivity to redox
conditions [17]. Therefore, it was proposed that SelN regulates
calcium homeostasis by modulating RyR redox status. Moreover,
recent in vitro studies demonstrated that SelN plays a role in cell
defense against oxidative stress; absence of SelN in human cells
resulted in a significant increase in basal intracellular oxidant
activity and protein oxidation, as well as an increased susceptibility
to exogenous oxidative stress [18]. The conclusion of these
experiments positions SelN as a key regulator of cell stress, redox
signaling and calcium homeostasis pathways (reviewed in [12]).
Although Sepn1 mRNA and SelN protein were detected in
almost all human and mouse tissues [19,20], its deficiency is
associated with a muscle-specific dysfunction in humans. Interest-
ingly, SelN expression was higher in embryonic tissues compared
to adult. Furthermore, in vitro, its expression decreased during
myoblast differentiation [16]. In zebrafish and mouse embryos,
early embryonic expression of Sepn1 was reported to be mostly
abundant in somites, the precursors of muscle structures,
diminishing throughout muscle differentiation [20,21]. This
expression pattern is in favor of a role for SelN in muscle
development. Consistently, morpholino-mediated inhibition of the
sepn1 gene expression in zebrafish caused marked developmental
defects in somite organization, establishment of slow fibers and
muscle architecture, impairing embryo motility [17,22].
To determine the role of SelN in vivo and to analyze the
implications of its deficiency, we developed a Sepn1 knock-out
mouse model that constitutes the first mammalian model for
SEPN1-RM. We recently showed that SelN deficiency does not
alter somitogenesis or the expression of myogenic factors in this
model. This result contrasted with those obtained in zebrafish,
suggesting that SelN is dispensable for normal embryogenesis in
mouse [20]. Here, we demonstrate that SelN-deficient adult mice
do not spontaneously develop muscle disorders and are indistin-
guishable from wild-type, although subtle muscle alterations could
be detected. Hence, effect of SEPN1 mutation is markedly different
in mouse and human, limiting the use of these Sepn12/2 mice as a
clinical model for SEPN1-RM. Importantly, mutant mice display
increased susceptibility to swimming-induced exercise and stress;
under these conditions, Sepn1 mutant mice developed muscle
atrophy, predominantly affecting trunk muscles and leading to
severe kyphosis. These features are reminiscent of the axial
weakness distribution and scoliosis characteristic of SEPN1-RM
patients. Therefore, we propose that this model constitutes a useful
tool to clarify the role(s) of SelN, to better understand the
pathophysiological mechanisms underlying SEPN1-RM and the
influence of environmental factors in the severity and progression
of these muscular disorders.
Results
Excision of Sepn1 exon 3 disables SelN expression, but
leads to no obvious macroscopic phenotype in the
Sepn1-null mice
A 7 kb genomic fragment, spanning exons 1 to 5 of the murine
Sepn1 gene, was obtained by screening a mouse 129 Sv Pas
genomic library. Heterozygous (L3/+) and (L2/+) Sepn1-floxed 129
Sv ES cell lines were generated using a gene-targeting vector in
which loxP sites were inserted to flank the murine exon 3
(Figure 1A). The obtained ES cells were injected into C57BL/6J
blastocysts. Splicing of the modified Sepn1 mRNA after Cre-
mediated excision resulted in a frameshift downstream of exon 2
and introduced several stop codons within exon 6. Sepn1 knock-out
animals were obtained by breeding L3/L3 floxed mice with mice
expressing Cre ubiquitously under the control of the CMV
minimal promoter, leading to Sepn1 gene disruption in the
germinal lineage and transmission of the mutant allele to offspring.
The resulting progenies were genotyped by PCR using primers
that specifically targeted the deleted exon 3 (Figure 1B).
Sepn1 transcript expression in Sepn1+/+, Sepn1+/2 and Sepn12/2
littermate mice was quantified by qRT-PCR in several isolated
tissues. We observed an almost complete disappearance of the
mRNA in homozygous tissues, while its expression was reduced by
two-fold in heterozygous, compared to wild-types (Figure 1C and
data not shown). These results showed that removal of the third
exon led to the destabilization and degradation of the Sepn1
transcript, most likely due to the occurrence of premature stop
codons. Accordingly, SelN expression was undetectable in Sepn12/2
mice by Western blot using protein extracts from different tissues,
while it was clearly observed in all wild-type tissues, although at
different levels (Figure 1D). These results verify that, as expected,
excision of exon 3 constitutively disabled SelN synthesis in all tissues.
Out of 123 pups born from heterozygous Sepn1+/2 intercrosses,
32 were Sepn1+/+ (26%), 58 Sepn1+/2 (47.2%) and 33 Sepn12/2
(26.8%). These results are consistent with Mendelian ratios
suggesting that SelN is dispensable for normal embryonic
development in mice. This observation is also in agreement with
our previous results demonstrating the lack of embryonic
developmental phenotype [20]. Moreover, Sepn12/2 mice were
healthy, fertile, and appeared indistinguishable from wild-type and
heterozygous littermates from birth to adult stages. No significant
difference in growth rate was observed between the two groups
(Figure 1E). Sepn12/2 and control mice had a similar life
expectancy, Sepn12/2 individuals reaching adulthood without
developing any specific phenotype. Macroscopic and histological
examination of several non-muscle organs (see Material &
Methods) revealed no obvious anomalies in the Sepn1-null mice
(data not shown).
SelN-deficient mice were ambulant and displayed no reduction
of spontaneous activity. Functional and behavioral tests showed no
significant differences compared to wild-types: Sepn12/2 mice
exhibited no perturbations in their running performance, even
after repeated treadmill training (see Data S1), and adapted to the
rotarod test as efficiently as controls. These results demonstrate
that SelN is dispensable for post-natal development, growth and
normal activity in this model under standard breeding conditions.
Similar results were obtained with the muscle-specific knockout
mice obtained by crossing Sepn1 L2/L2 with Actin-Cre mice (data
not shown). Taking into account the conservative phenotype, we
next focused our attention on the ubiquitous knock-out strain.
A Mouse Model for SEPN1-Related Myopathy
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Muscle structure and function show only subtle changes
in Sepn1 knock-out mice under basal conditions
A comprehensive analysis of Sepn12/2 muscle tissue was
performed. Relative to body weight, individual skeletal muscle
masses from 3 and 10 month-old mutant mice were not statistically
different from control, except for the tibialis anterior (TA) muscle
which was significantly reduced at both ages (wild-type: 0.164+/
20.002%, Sepn12/2: 0.151+/20.003% at 3 months, p = 0.0028;
wild-type: 0.177+/20.003%, Sepn12/2: 0.147+/20.005% at 10
months, p = 0.015). Maximal force production was measured in
situ in TA muscles from 3 month-old mice and revealed a 15%
reduction in the absolute maximal force (P0) in Sepn1
2/2 females
compared to controls, while the specific maximal force (sP0) was
unchanged (Table 1). These results indicate that hindlimb muscle
contractility was not markedly affected in the absence of SelN.
Standard histological analyses were performed on hindlimb and
paravertebral muscles, as well as diaphragm, from 1, 6 and 9–12
month-old mice. At all ages studied, haematoxylin and eosin (HE)
staining revealed normal muscle organization, with no sign of
necrosis/regeneration, inflammation or endomysial fibrosis in any
of the mutant muscles (Figure 2A and data not shown). The
percentage of central nuclei was not increased in mutant mice at
any of the ages studied, compared to wild-types. Moreover,
reduced nicotinamide adenine dinucleotide-tetrazolium reductase
(NADH-TR), succinate dehydrogenase (SDH) and cytochrome c
oxidase (COX) staining showed an identical distribution of
sarcoplasmic reticulum (SR) and mitochondria in wild-type and
Sepn12/2 muscles (Figure 2A). In Sepn12/2 males, modified
gomori trichrome (GT) staining detected focal aggregates in less
than 1% of the fibers in TA and quadriceps, which were similarly
observed in wild-type littermates. Periodic acid Shiff (PAS) and oil
Red O (ORO) colorations revealed no change in the glycogen and
lipid content of mutant muscles compared to wild-types (data not
shown).
Based on immunostaining of the different myosin heavy chain
(MHC) isoforms, we also demonstrated that embryonic MHC
positive fibers were detected only rarely in Sepn1-null adult
muscles, consistent with the absence of necrosis/regeneration
events (data not shown). Measurement of fiber minimum
diameter, based on laminin immunostaining, at 10 months of
Figure 1. Generation of the Sepn1 knock-out mouse model. A) Strategy for the selective excision of Sepn1 exon 3. In the targeting fragment,
LoxP sites were incorporated on each side of exon 3 together with a floxed neomycin (neo) cassette (L3). This fragment was electroporated into ES
cells and neo-resistant clones that featured homologous recombination were selected. In vivo or ex vivo Cre-induced excision of floxed regions
leading to neo excision (L2) or complete excision (L-) are represented. B) Mice genotyping. PCR were performed on genomic DNA extracted from
Sepn1+/+, Sepn1+/2 and Sepn12/2 mice. Exon 3 excision leads to a 500 bp loss in the PCR product size. The bands at 1000 and 490 bp represent the
wild-type and the exon 3-deleted alleles, respectively. C) Expression of Sepn1 transcript in Sepn1+/+, Sepn1+/2 and Sepn12/2 tissues. Brain, quadriceps
(quad) and diaphragm (diaph) were tested. Quantification was performed by qRT-PCR and normalized to the 18S gene expression. n = 3, *, p,0.05;
**, p,0.01. D) Selenoprotein N (SelN) expression. Western blot analysis was performed using total protein extracts from several tissues (Sk M, skeletal
muscle) of Sepn12/2 and Sepn1+/+ mice. GAPDH was used as a loading control. E) Body weight analysis. Body weight evolution of wild-type or
mutant, male or female mice, from 5 to 40 weeks of age was monitored. Similar growth curves were observed for mutant and control mice of both
genders.
doi:10.1371/journal.pone.0023094.g001
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age in TA and quadriceps muscles showed similar fiber size
distribution between mutant and control mice of the two groups
(Figure 2B). In contrast, a slight shift toward smaller fibers was
observed in the paravertebral muscles (Figure 2B). Fibers of types
I, IIA, IIX and IIB in hindlimb and back muscles were in equal
proportions between mutant and control mice (Figure 2C).
To proceed further, electron microscopy (EM) analyses were
performed on quadriceps and gastrocnemius muscles from 1 and 6
month-old mice. At both ages, EM studies disclosed a global
normal ultrastructure in terms of sarcomere organization,
mitochondria distribution or morphology, nuclei appearance and
myotendinous junction structure (Figure 3A). No core lesion was
observed. Moreover, the SR and T-tubules, including triads,
appeared correctly arranged in mutant muscles (Figure 3A).
Because of the proposed interaction between SelN and the
ryanodine receptor RyR [17], expression levels and localization of
these channels were investigated in the Sepn12/2 muscles. Western
blot analysis showed that expression levels of RyR1 and RyR3, as
well as other components of the triadic junction, the dihydropyr-
idine receptor (DHPR) and the triadin isoform Trisk95, were not
modified in the SelN-deficient muscles (Figure 3B). Immunostain-
ing for RyR1, RyR3 and DHPR revealed normal intracellular
distribution and colocalization at the triad sites (Figure 3C).
Taken together, these data revealed that SelN-deficient mouse
muscles displayed only subtle abnormalities (TA atrophy and mild
decrease in the absolute maximal tetanic force, reduced fiber size
diameter in paravertebral muscles) under normal housing
conditions.
Expression levels of other selenoproteins are not
modified in Sepn12/2 mouse
In light of this lack of obvious phenotype in SelN-deficient mice,
the expression of several other selenoproteins was quantified in
isolated tissues (brain, diaphragm and quadriceps) from mutant
mice and compared to wild-types. We chose to quantify their
expression levels at late embryonic stages because of the high
expression of SelN at this stage. No significant difference was
detected in the transcript expression levels of these proteins, except
for selenoprotein R (SelR) which appeared increased in Sepn12/2
quadriceps, although to a limited extent, 1.5 fold (Figure S1).
These results suggest that no functional compensation between
selenoproteins occurred.
Stress conditions trigger a pathological phenotype in
Sepn1 knock-out mice
Mice were submitted to repeated forced swimming tests (FST),
which, in addition to the increased physical activity, simulta-
neously provides a global stress context resulting in a combina-
tion of environmental, respiration and temperature stresses. Two
groups of mice, aged 4–5 and 12 months, were subjected to up to
15 minutes of active swimming, every other day for three
months. During the training period, Sepn12/2 mice adapted to
the test similarly to wild-types. However, after four to six weeks,
most Sepn12/2 mice developed, during and following the
swimming exercise, an obvious phenotype characterized by a
progressive rigidity of the trunk and limbs and a drastic
reduction in motility (see Movie S1). There was some degree
of variability in the severity and time of appearance of the
phenotype among different knock-out animals. In the final
stages, body rigidity persisted for several minutes after the
swimming period, after which the mice recovered their normal
mobility. In addition, mutant mice developed a severe kyphosis
that worsened with repeated FST and was more marked in older
mice; this kyphosis was initially transient and evolved progres-
sively to an abnormal, permanent, ‘‘crouched’’ attitude
(Figure 4A). Tomographic investigation showed a marked
curvature of the spine in its central part (Figure 4B). The
kyphotic angles (Th7-L4) were measured in older mice using the
Cobb method [23]. The thoracic angle was around 76 degrees
for control mice, increasing to 100–110 degrees in Sepn12/2
mice. These results show that SelN-deficient mice display an
enhanced susceptibility to physical exercise when performed
under stress conditions, such as FST.
Following 1.5 months of FST, mutant mice from the younger
group exhibited a reduced gain in body weight compared to wild-
types (Figure 4C). Furthermore, masses of TA, quadriceps,
gastrocnemius and extensor digitorum longus (EDL) muscles,
normalized to the body weight, were significantly reduced in
Sepn12/2 mice, compared to controls (Figure 4D). No difference
was detected for diaphragm and heart. In older mice, paraverte-
bral muscles appeared macroscopically atrophic, while hindlimb
muscles were relatively preserved, and tomography imaging
confirmed an atrophic aspect of the trunk (Figure S2). In situ
measurement of the absolute maximal tetanic forces revealed a
significant 19% reduction of TA muscles from mutant males,
whereas it was decreased to a lesser extent in females from the
younger group. In both genders, the specific maximal force of TA
and diaphragm was preserved, indicating that contractility of the
fibers was unaltered (Table 1). TA and diaphragm response to
fatigue, represented by the F30%, was not affected in mutant mice
submitted to FST (Table 1).
Histological analyses after FST revealed absence of necrosis,
regeneration, endomysial fibrosis or cores in both mutant and
wild-type muscles (Figure 5A); the distribution of oxidative
activity was comparable in both groups and identical to basal
conditions. Only in one 12 month-old Sepn12/2 animal, the
most affected one, an increased number of centrally located
nuclei (25% of fibers) was observed in paravertebral muscles,
Table 1. Contractile properties of tibialis anterior (TA) and
diaphragm muscles, in basal conditions and after FST.
Males Females
Sepn1+/+ Sepn12/2 Sepn1+/+ Sepn12/2
TA
Mass (mg) 57.461.8 53.862.5 38.561.2 37.861.3
P0 (mN) 1132.8679.4 1227.7694.8 867.5633.6 741.5630.7
a
sP0 (N/g) 19.760.8 22.960.9 22.660.9 19.861.3
TA – FST
Mass (mg) 55.463.3 43.861.9b 39.661.3 36.761.6
P0 (mN) 1167.5674.4 957.2647.5
a 801.4638.5 703.6662.3
sP0 (N/g) 21.160.6 21.860.7 20.461.0 19.161.3
F30% (s) 32.561.8 33.961.9 29.865.0 29.163.7
Diaphragm – FST
sP0 (N/mm
2) 168.7613.5 135.1610.1
F30% (s) 38.161.3 42.564.5
P0, absolute maximal force; sP0, specific maximal force; F30%. time for initial
maximal force to fall by 30%. Statistical comparison was performed using a
Student t test. Group in basal conditions: n.6 for females. n.3 for males.
Group with FST: n.7 for TA females. n.9 for TA males. n.5 for diaphragm.
Statistical analysis:
aP,0.05.
bP,0.01 compared to wild-type.
doi:10.1371/journal.pone.0023094.t001
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which were atrophic. In the younger group (7–8 month-old at
the end of the test), few large tubular aggregates were detected
by modified Gomori Trichrome (GT) coloration in quadriceps
and back muscles in mutant mice, while only rare ones could be
observed in wild-types (Figure 5A). These tubular aggregates
were much more abundant in older mice and present in both
female and male Sepn12/2 mice. Histochemical and EM
analyses revealed their presence in a majority of fibers from
mutant quadriceps, gastrocnemius, TA and, to a lesser extent,
soleus and paravertebral muscles (Figure 5A and 5B). Immu-
nohistochemical studies showed accumulation of triadic junction
proteins including RyR1, RyR3, triadin and DHPR in these
aggregates, suggesting a SR origin (Figure S3). Determination of the
fiber size distribution demonstrated that the fiber hypotrophy
observed in mutant back muscles (Figure 2B) worsened as a
consequence of FST (Figure 5C). Immunostaining against different
MHC revealed an important switch in the fiber type distribution in
Sepn12/2 paravertebral muscles, from type IIB to types IIX and IIA,
compared to wild-types (Figure 5D). In the mutant hindlimb
muscles, only a limited shift toward smaller fibers and no alteration
in fiber types were observed (Figure 5C and 5D).
Taken together, these results demonstrated that Sepn12/2 mice
are indeed affected by swimming-induced exercise and stress,
leading to kyphosis and predominant alteration of back muscles. In
addition, we observed a switch toward slower/smaller fibers and
the accumulation of tubular aggregates.
Discussion
SEPN1-Related Myopathy describes a group of muscle diseases,
clinically homogeneous although with variable severity, all caused
by mutations in the gene encoding selenoprotein N (SelN). The
main characteristic features are prevalent atrophy and weakness of
trunk muscles, which are present from infancy but lead to
complications such as scoliosis and respiratory failure later in life.
To date, no curative treatment is available, and the pathophys-
iological mechanisms remain largely unknown. In this context,
development of animal models reproducing the biochemical defect
of the human condition is an important step. In this report, we
describe for the first time a mammalian model for SelN deficiency,
obtained by inactivation of the Sepn1 gene in mice. Sepn12/2 mice
were healthy and macroscopically indistinguishable from wild-type
littermates. More surprisingly, we detected only subtle alterations
in the morphology, ultrastructure and contractility of the mutant
muscles. Together with our previous studies on embryonic
development [20], these observations demonstrate that SelN is
dispensable for survival, muscle development and muscle main-
tenance in mice, at least under basal housing conditions.
This absence of a major phenotype contrasts with the marked
muscle defects observed in zebrafish morpholino mutants. In
SelN-depleted zebrafish embryos, major developmental defects
and important alteration of muscle architecture were observed
[17,22]. It was notably shown that SelN plays an important role
Figure 2. Histomorphology of Sepn12/2 adult muscles. A) Representative image of quadriceps cryosections, stained with HE, NADH-TR and GT,
from 10 month-old mutant and control mice. Mutant muscle displayed no obvious histopathological abnormalities. Scale bar, 50 mm. B) Fiber size
distribution (% of total number of fibers) according to their minimum diameter (mm) for TA and quadriceps muscles (left panel) and paravertebral (PV)
muscles (right panel) from 10 month-old mutant and wild-type mice. A switch toward smaller fibers was observed in Sepn12/2 PV muscles compared
to wild-types. n = 3, * p,0.05; ** p,0.001. C) Fiber type distribution (% of total number of fibers) based on type I and II MHC immunostaining of
paravertebral and quadriceps muscles, from 10 month-old mice. No significant difference was found between mutant and control mice. n = 3. Data
are means6SEM.
doi:10.1371/journal.pone.0023094.g002
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for proper development of the slow muscle fiber lineage. This
defect in the establishment and maintenance of slow fibers was not
observed in the Sepn12/2 mouse. In addition, an alteration in the
myoseptum structures was seen in mutant zebrafish, suggesting a
possible function for SelN in the establishment of myotendinous
junctions, the mammalian analogs of myosepta. This hypothesis
could be excluded in our mouse model since EM analyses showed
normal myotendinous junctions in all muscles examined (data not
shown). In addition, a functional link between SelN and RyR was
proposed, consistent with the alterations of calcium dynamics and
triad structures detected in the zebrafish mutants [17]. Here we
show that RyR1 and RyR3 expression and localization, as well as
the structure of the triadic junctions, are not affected by SelN
depletion in mice. RyR activity was not addressed in this study,
but considering the preserved contractility of the Sepn12/2
muscles, it is unlikely that SelN deficiency drastically impairs
RyR channel regulation, which would result in a severe
perturbation of excitation-contraction coupling. One possible
explanation is that the divergent phenotypes observed in zebrafish
and mice may reflect existing differences in muscle development
and physiology between the two species, and/or that SelN plays
distinct functions in the two species. Similarly, the differences
between the basal phenotype of our murine model and the
symptoms described in SEPN1-RM patients is intriguing, but not
exceptional: many mutations causing genetic neuromuscular
diseases in humans lead to a mild phenotype once transposed to
a mouse model [24,25]. The absence of basal phenotype in the
Sepn12/2 mice might result from the obvious differences existing
between mice and human, including differential use of specific
muscles, such as postural muscles. The human myopathy involves
predominantly muscles which are constantly active, particularly
postural back muscles whose tonic activity maintains the upright
position, a situation clearly different for rodents. In addition,
SEPN1-RM patients are ambulant and usually lead an active,
close-to-normal life before the full phenotype develops in puberty
[15]. In contrast, standard mouse housing conditions provide a
Figure 3. Ultrastructural organization and triadic junctions in Sepn12/2 adult muscles. A) Electron microscopy image of gastrocnemius
muscles from 6 month-old wild-type and mutant mice. No defect in sarcomere organization, mitochondria morphology (arrows) and triads structure
(brackets) were observed in mutant (right panel), compared to wild-types (left panel). Scale bars, 1 mm (top) and 100 nm (bottom). B)
Immunostaining for DHPR (green) and RyR1 or RyR3 (red) on longitudinal sections of quadriceps from 2 month-old mice, revealing normal
localization of both receptors in mutant mice compared to controls. Nuclei are revealed by DAPI staining. Boxed regions in the merged images are
magnified as inserts (right) showing intracellular co-localization (yellow). Scale bar is 10 mm. C) Skeletal muscle microsomes extracts from Sepn1+/+ or
Sepn12/2 littermates were immunoblotted for Ryanodine Receptor type 1 (RyR1), Ryanodine Receptor type 3 (RyR3), Dihydropyridine Receptor
(DHPR), Selenoprotein N (SelN) and triadin isoform Trisk 95 (Trisk 95).
doi:10.1371/journal.pone.0023094.g003
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stable environment, with restricted physical activity and controlled
conditions of temperature or other potential stressors, which could
contribute to protect these mice from spontaneous development of
the phenotype.
Interestingly, while running tests failed to demonstrate or to
induce any defects in SelN-deficient muscles, homozygous Sepn12/2
animals developed a pronounced phenotype when submitted to
repeated forced swimming tests (FST). We decided to challenge our
model with FST because this test associates physical exercise with a
combination of behavior and environmental stresses. Indeed, FST is
a widely used procedure to assess depression in mice, because it
provides a context for global stress induction [26–28]. Moreover,
Figure 4. Global phenotype of Sepn12/2 mice submitted to repeated forced swimming tests (FST). A) Global appearance of 8 and 14
month-old wild-type and mutant mice, after 3 months of FST. A severe kyphosis was observed in both young and older mutant mice, while no sign of
kyphosis was present in wild-type animals. B) Sagittal tomography of wild-type and mutant mice placed in ventral position, indicating a marked axial
distortion of the spine in Sepn12/2 animals (arrows). C) Gain of body mass for wild-type and mutant mice, after 1.5 and 3 months of FST. The gain was
significantly lower in mutant mice, compared to wild-types, at both stages. n = 20 Sepn1+/+ vs. 22 Sepn12/2 for 1.5 months, n = 14 Sepn1+/+ vs. 22
Sepn12/2 for 3 months. * p,0.01, ** p,0.0005. D) Muscle masses normalized to body weight (%) in wild-type and mutant mice after 3 months of
FST. Atrophy was observed for TA, quadriceps (Quad), gastrocnemius/plantaris/soleus muscles group (GPS) and extensor digitorum longus (EDL)
muscles from mutant mice, compared to wild-types. Diaphragm (Diaph) and heart masses were not affected. n = 11 Sepn1+/+ vs. 16 Sepn12/2 (except
for diaphragm: n= 8 Sepn1+/+ vs. 10 Sepn12/2), * p,0.05, ** p,0.001, *** p,0.0005, **** p,0.0001. Data are means6SEM.
doi:10.1371/journal.pone.0023094.g004
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Figure 5. Histomorphology of Sepn12/2 muscles after 3 months of FST. A) Representative images of quadriceps sections, stained with HE,
NADH-TR and GT, from 8 and 14 month-old mice submitted to 3 months of FST, as indicated. Cytoplasmic inclusions, stained in red by GT (arrows),
were detected in several muscle fibers from young mice, and were much more abundant in old mutant mice. Aggregates were only occasionally
observed in Sepn1+/+ mice. Scale bar, 50 mm. B) Representative images of tubular aggregates observed in mutant quadriceps (left panel) and
gastrocnemius (right panel) from old mutant mice, after FST, by electron microscopy. Accumulation of sarcoplasmic reticulum membranes was
observed in the majority of mutant fibers, leading to large aggregates inclusions in the cytoplasm. Scale bar, 1 mm. C) Fiber size distribution,
according to their minimum diameter (mm), for TA and quadriceps muscles (right panel) and paravertebral muscles (left panel) from 8 month-old
mice, at the end of the test. Selective specific switch towards smaller fibers was observed in mutant paravertebral muscles, while no major alteration
was detected for other muscles. n = 4 Sepn1+/+ vs. 6 Sepn12/2, * p,0.05. D) Fiber type repartition (% of total number of fibers) based on type I and II
MHC immunostaining for paravertebral and quadriceps muscles, from 8 month-old mice, after FST. Significant switch from type IIB to types IIX and IIA
was only observed for paravertebral muscles in mutant mice, compared to wild-types. n = 4 Sepn1+/+ vs. 6 Sepn12/2, * p,0.005, ** p,0.001. Data are
means6SEM.
doi:10.1371/journal.pone.0023094.g005
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during the swimming sessions, mouse back and neck muscles are
strongly solicited, since they are submitted to constant isometric
contractions in order to maintain the swimming posture. After
repeated swimming sessions, Sepn12/2 mice developed symptoms
reminiscent of the clinical spectrum described in SEPN1-RM
patients, with a predominant effect on trunk muscles leading to a
marked deformation of the spine and, at the cellular level, an
abnormal switch toward smaller and slower fibers. Overall, this
reveals a striking sensitivity of exercised SelN-deficient muscle to
a recurrent stress context. In addition, our results demonstrate the
important involvement of SelN in muscle physiology, since no
other obvious defects were observed in any of the other organs
analyzed.
As mentioned previously in patients, clinical signs are highly
homogeneous and recognizable, but the severity and spectrum of
histopathological presentations are variable [29]. In a recent
publication, Cagliani and collaborators [14] described three
families harboring SEPN1 mutations with symptoms ranging from
the severe early-onset rigid spine syndrome requiring early spinal
fusion and assisted ventilation to more benign forms without major
scoliosis. We also previously reported one patient with a mild
phenotype first referred in her 30s, despite the almost complete
absence of SelN expression [13]. This variability in the clinical
severity, regardless of the nature and position of the mutation,
suggests that other elements modulate the degree of the phenotype
in humans; these could be unknown genetic variants but also non-
genetic factors, in particular involvement of environmental and/or
physiological stresses in the aggravation of the pathology. In this
context, our animal model will be useful to evaluate the role of
exercise and additional factors, such as nutritional or pharmaco-
logical, in the pathogenic mechanism of the disease.
We recently showed that SelN plays a major role in satellite cell
maintenance in adult skeletal muscles, a mechanism essential for
muscle regeneration under basal conditions and even more in an
acute stress context, i.e. following cardiotoxin-induced necrosis/
injury [30]. Hence, after two rounds of injury, a major impairment
of the regeneration process was observed with drastic atrophy of
the muscle. The absence of a basal phenotype in the Sepn12/2
mouse model indicates that this defect in satellite cell dynamics is
nevertheless compatible with correct development, growth and
maintenance of skeletal muscle tissues. In the FST conditions, we
found that satellite cells were activated neither in wild-type nor in
mutant mice (data not shown), suggesting that the abnormal
phenotype developed by mutant mice is independent from the
satellite cell defect. These observations suggest that SelN
participates in at least two distinct (but not mutually exclusive)
processes, namely, muscle progenitor maintenance and mature
fiber homeostasis.
In the Sepn12/2 mouse model, the phenotype observed in the
FST conditions developed after several repetitions of the
swimming session, suggesting a cumulative process that progres-
sively impairs muscle function. Previous studies based on ex vivo
analyses of human cells indicated that SelN is involved in oxidative
homeostasis in cells [18]. Accordingly, Oxyblot analysis revealed a
significant increase in the overall content of carbonylated proteins
in SelN-deficient quadriceps, but not in paravertebral muscles,
under basal conditions (Figure S4). In the FST context, one
explanation for the muscle alterations in mutants is that training
induces an elevated tissue oxidation process, due to a combination
of increased activity and stress. Interestingly, while FST induced
an increase in oxidized protein content in quadriceps from both
wild-type and mutant mice, in paravertebral muscles increased
protein oxidation was observed in the mutant mice exclusively
(Figure S4). This result suggested a different ability of mutant and
wild-type paravertebral muscles to respond to stress and exercise.
One remaining question is how the abnormal oxidative conditions
resulting from FST would induce the alterations observed in the
Sepn12/2 muscles, including the tubular aggregates and the fiber
hypotrophy, notably in paravertebral muscles. It has been
established that free radicals generated by oxidative stress in
muscle disuse context participate in proteolysis induction and
muscle atrophy [31,32]. Moreover, disequilibrium in the redox
potential within the muscle fiber could result in reticular stress and
calcium homeostasis dysregulation [33,34]. Thus, it seems possible
that in the absence of SelN and in a situation of exercise and/or
stress, altered oxidative conditions may lead to perturbed RyR
activity. The subsequent altered calcium dynamics could then be
responsible for atrophy, by activation of Ca2+-dependent proteas-
es, and fiber type switch, by modifying the calcineurin pathway
[35,36]. Furthermore, it was shown that sarcoplasmic reticulum
stress is responsible for tubular aggregate accumulation as an
adaptive response to increased calcium influx [37–39].
Most members of the selenoprotein family, at least those with
known functions, are enzymes involved in oxidation-reduction
reactions and have been implicated in oxidative stress regulation
[40]. Some selenoproteins, such as glutathione peroxidase 1
(GPx1), thioredoxin reductase (TrxR) and possibly selenoprotein P
(SelP), are involved in the detoxification of reactive oxygen species.
Others like methionine sulfoxyreductases (Msr) or phospholipid
hydroperoxide glutathione peroxidase (GPx4) are involved in
oxidative damage repair [41]. The molecular function of SelN is
still elusive; whether it contributes to the maintenance of the redox
homeostasis within the endoplasmic reticulum or controls more
specific redox-regulated targets remains to be determined. One
possible hypothesis, which we investigated in light of the mild
muscle phenotype obtained in the Sepn12/2 mice, was a
compensatory expression of other selenoprotein(s). Our data
revealed no major change in the expression of selenoprotein
transcripts, suggesting no functional redundancy between SelN
and another protein of this family (Figure S1). Other enzymes or
molecules involved in oxidative stress response may rather
compensate the absence of SelN. One interesting candidate is
vitamin E or a-tocopherol, a liposoluble antioxydant known to be
involved in oxidative stress protection. Indeed, combined selenium
and vitamin E nutritional deficiency has been linked to several
muscle syndromes in both human and cattle [42]; reviewed in [6].
Moreover, N-acetylcysteine (NAC), a thiol donor that increases
glutathione synthesis, was recently shown to reduce protein
oxidation and protect SelN-deficient fibroblasts from cell death
under oxidative stress conditions. Therefore, NAC has been
envisioned as a potential treatment for individuals affected with
SEPN1-RM [18]. The Sepn12/2 mouse model submitted to the
exercise conditions described here will be useful to test this
strategy.
In conclusion, we propose that despite the lack of a spontaneous
phenotype, the Sepn1 knock-out mice presented in this study
constitute a useful tool to clarify the function(s) of SelN and to
better understand the pathophysiological mechanisms underlying
SEPN1-RM. While there was no obvious phenotype in normal
housing conditions, we showed mild hypotrophy and absolute
maximal force reduction in TA, limited fiber size modification in
paravertebral muscles and an increase in oxidized protein levels;
these data suggest that the pathophysiological process may already
be on-going although not readily observable. In addition, specific
experimental conditions demonstrated a particular susceptibility of
Sepn12/2 muscles to exercise in a stress context, and led to a clear
muscle phenotype whose distribution is comparable to that of
SEPN1-RM patients. Therefore, further studies in this animal
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model will provide important clues to understand the influence of
environmental factors in the disease pathogenesis, severity and
progression, and might be helpful to identify and investigate
potential therapeutic targets.
Materials and Methods
Generation of the Sepn1 knock-out mice
Generation of the Sepn12/2 mice was performed in partnership
with the Mouse Clinic Institute (Illkirch, France), according to
previously described protocols [43]. Recombinant ES cell lines,
derived from the 129 Sv Pas line [43], were screened by PCR to
verify the correct recombination at the expected position within
the genome, and Southern-blot analysis was carried out to ensure
that the selected clones underwent a single and correct
homologous recombination event. Genetically modified Sepn1-L2
and -L3 ES cell lines were injected into blastocysts arising from
pseudo-pregnant C57/B6 J host females. Chimeric males were
obtained for both transgenes and crossed with C57/B6 J females.
The heterozygous offspring were then intercrossed to obtain
homozygous (L2/L2) and (L3/L3) mice. For knock-out of the Sepn1
gene, L3/L3 animals were bred with CMV-Cre mice. Constitutive
expression of the Cre-recombinase in these mice led to the
complete excision of both exon 3 and the Neo cassette, in
particular within the germinal cell lineage and thus transmission of
the disrupted gene (L-) to offspring. Heterozygous Sepn1+/2 mice
for the transgene were backcrossed to wild-type mice to remove
the Cre gene. Intercrosses of heterozygous animals gave wild-type,
heterozygous and knockout mice on a mixed C57/Bl6-129Sv
background. Procedures involving animals and their care were
conducted according to the European Union guidelines for animal
care. Animal experimental procedures were evaluated and
approved by CREMEAS (Comite´ Re´gional d’Ethique en Matie`re
d’Expe´rimentation Animale de Strasbourg), number 2003-10-
08[2], and by DDPP (Direction De´partementale de la Protection
des Populations), numbers D67-218-5 and 67-234. Genetically
modified ES cell lines Sepn1-L2 and –L3, as well as the
transgenique mouse Sepn1-K51 line were declared to Haut Conseil
des Biotechnologies – Ministe`re de l9Enseignement Supe´rieur et de
la Recherche, and registered under numbers 4465 of 26/05/2005
and 4712 of 26/05/2006.
Forced Swimming Test (FST)
FST was performed as previously described [44]. Briefly, mice
were submitted to FST in a plastic tank filled with 20 cm water,
with no more than 3 mice per tank. Water temperature was
maintained at 20uC. Mice were carefully placed into the water and
their behavior was monitored. Mice were stimulated for active
swimming by gentle pushes. The test was repeated every other day
with a time increment of 1 min after each test (beginning at 6 min)
until a swimming phase of 15 min was achieved over 3 months. At
the end of each swimming session, mice were carefully dried and
warmed under infrared light for 10 min.
qRT-PCR analysis
Total RNA was extracted using the RNeasy Fibrous Tissue
Mini Kit (Qiagen) according to the manufacturer’s instructions.
cDNA was synthesized from 500 ng of RNA with random
hexamer primers using the SuperScript First-Strand Synthesis
System for RT-PCR (Invitrogen). Sepn1 transcripts were quantified
as previously described [20]. Data were analyzed using the
LightCycler480 analysis software (Roche). Primers used are listed
in Table S1.
Western blot analysis
Frozen tissues were ground in liquid nitrogen and homogenized
in protein extraction buffer (80 mM Tris-HCl, pH 6.8, 10% SDS,
120 mM sucrose, 10 mM EDTA, 1 mM PMSF and 1 mM
benzamidine). Homogenates were incubated for 10 min at 55uC,
sonicated twice and quantified with the BCA Protein Assay
(Pierce). 60 mg of proteins were electrophoretically separated on
8% polyacrylamide SDS gel and transferred to a polyvinylidene
difluoride membrane (Invitrogen). Membranes were immuno-
probed with rabbit anti-SelN (ab137) [16] and rabbit anti-actin
(Sigma A2066) primary antibodies. Membranes were then
incubated with HRP-conjugated secondary antibodies (Dako).
Signals were detected with chemiluminescent HRP substrate
(Immobilon Western - Millipore) on a G-Box-Chemimager
(SynGene instrument, Ozyme).
Muscle microsome preparation
RyR1, RyR3, DHPR and Trisk95 analysis were performed on
membrane microsomes prepared from freshly dissected mouse
skeletal muscles. Tissue was homogenized by dounce (1–2 g
muscle/10 ml 200 mM sucrose, 20 mM HEPES pH 7.4, 0.4 mM
CaCl2, 100 mM PMSF) and centrifuged at 1,400 g for 10 min.
The resulting supernatant was centrifuged (41,000 g, 50 min), and
the microsome pellet was resuspended in a 0.1 M NaCl, 30 mM
imidazole pH 6.8, 8% sucrose buffer with protease inhibitors.
Western blot analysis was performed as described above.
Histological and ultrastructural analyses
Neural tube, eye, bladder, kidney, testis, intestine, stomach,
liver, pancreas, brown fat, ligaments, bones and skin were analysed
with standard histological staining performed on cryosections from
E18 whole mouse embryo.
Muscles from Sepn12/2 and paired wild-type animals of three
different age groups (n$3 per group) were dissected and frozen in
liquid nitrogen-cooled isopentane. Cryostat sections were stained
with Hematoxylin/Eosin (HE), nicotinamide adenine dinucleo-
tide-tetrazolium reductase (NADH-TR), succinate deshydrogenase
(SDH), cytochrome c oxidase (COX), modified Gomori Tri-
chrome (GT), periodic acid Schiff (PAS) and Oil Red O by
classical methods (Dubowitzand and Sewry, 2007). Light micros-
copy observations were performed on quadriceps, tibialis anterior
(TA), soleus, gastrocnemius, diaphragm and paravertebral muscles
using an upright microscope (DMR, Leica) and 406 NA 0.85
HCX Plan Apo objective (Leica). Pictures were captured using a
monochrome camera (DS-Ri1, Nikon) and NIS-Elements BR
software (Nikon). Fiber size distribution was determined based on
laminin immunostaining performed on muscle sections, using the
NIS software (Nikon). Electron microscopy was performed on
gastrocnemius, quadriceps or TA muscles first fixed with 2.5%
glutaraldehyde in 0.1 M phosphate buffer (pH 7.4), and then with
2% OsO4 in 0.1 M phosphate buffer for 1 h at 4uC. Muscles were
then dehydrated at 4uC in graded acetone including a 2% uranyl
acetate in 70u acetone staining step, before Epon resin embedding.
Thin (70 nm) sections were stained with uranyl acetate and lead
citrate and observed using a Philips CM120 electron microscope
(Philips Electronics NV) and photographed with a digital SIS
Morada camera.
Immunohistochemistry
The following antibodies were used on 8 mm muscle cryosec-
tions: embryonic MHC (DSHB, F1.652), slow MHC (DSHB,
A4.840), fast MHC (DSHB, A4.74), DHPR, RyR3 (Chemicon,
MAB427 and AB9082, respectively), laminin (Abcam, ab11575),
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RyR1 and Trisk95 antibodies (kind gift from Dr. Isabelle Marty,
Grenoble Institut des Neurosciences, France). After microwave
oven antigen retrieval, sections were blocked with 3% IgG free
bovine serum albumin and ChromoPure Mouse IgG Fab
Fragments (Jackson ImmunoResearch). Sections were incubated
sequentially with primary antibodies and appropriate Alexa Fluor
secondary antibodies (Invitrogen). They were mounted in
Vectashield DAPI (Vector) and observed with an Axiophot
microscope (Zeiss). Images were captured using the MetaView
software (Ropper Scientific). RyR, DHPR and Trisk95 immuno-
stainings were performed as previously described [45].
Force measurement
The isometric contractile properties of TA muscles were studied
in situ, as previously described [46]. Force measurements in
diaphragm muscle were performed in vitro. Strips were dissected
from diaphragm muscles in situ and placed in a dish containing
oxygenated (95% O2 and 5% CO2) Tyrode’s solution (0.2 g.L
21
CaCl2 0.1 g.L
21 MgCl2 0.2 g.L
21 KCl 8 g.L21 NaCl 0.05 g.L21
NaH2PO4, 1 g.L
21 D-Glucose and 0.1 g.L21 NaHCO3, pH 7.4).
Diaphragm muscle strips were tied firmly with surgical silk at the
central tendon at one end and sutured through a portion of the rib
attached to the distal end of the strip at the other end. Muscle
strips were then transferred to a vertical bath filled with
oxygenated Krebs-Ringer solution. The absolute maximal force
(P0) was measured as described previously (Agbulut et al 2009).
The muscle strips were weighted and the specific force sP0 was
calculated as followed: sP0 = P0 (N)/muscle mass (g) or P0 (N)/
muscle area (mm2). Assuming muscles have a density of 1.06 mg/
mm3, the cross-sectional area corresponds to the volume of the
muscle divided by L0 (muscle length corresponding to maximal
force). Fatigue resistance was determined after a 5 min resting
period. Muscles were stimulated at 75 Hz during 500 ms every 2 s
for 3 min, and the time taken for initial force to decrease by 30%
(F30%) was determined.
Images and Statistical analyses
The MetaMorph (Molecular Devices) and NIS (Nikon) software
were used for cell counting and area measurement. Results are
presented as means 6 SEM of independent samples or animals; n
represents the number of individual experiment (n$3). Compar-
isons between groups were performed using the Student’s t-test
with a 0.05 level of confidence accepted for statistical significance.
Supporting Information
Figure S1 Selenoprotein expression in Sepn12/2mice at
E18. Expression of eleven selenoproteins was quantified in E18
Sepn1+/+ (black), Sepn12/+ (grey) and Sepn12/2 (white) embryos by
qRT-PCR. For all of them, expression was unaltered in brain,
quadriceps and diaphragm, with the exception of selenoprotein R
(SelR), which was significantly increased in Sepn12/2quadriceps.
n = 3. *, p,0.05.
(TIF)
Figure S2 Tomographic imaging shows an atrophic
aspect of axial muscles of Sepn12/2 mice after FST.
Coronal (A–C), sagittal (D–I) and transversal (J–O) sections of
wild-type and Sepn12/2 14 month-old mice submitted to FST; all
corresponding sections are from equivalent body positions for the
three animals. On coronal sections, Sepn12/2 mice (B, C)
appeared leaner and emaciated compared to wild-type (A).
Sagittal sections showed the diminution of the paravertebral
muscle mass (arrows) in the Sepn12/2 mice submitted to FST (E,
F). Moreover, increased curvature of the spine can clearly be
observed on sagittal sections of the Sepn12/2 mice (E, F, H and I),
this postural modification likely reflects the reduced tonicity of
Sepn12/2 mice trunk muscles. The atrophy of the paravertebral
muscles (circled with white dashed lines) is also observed on
transversal sections at the pelvic level (K, L), while hind-limb
muscles (delimitated by red dashed lines) appeared better
preserved (see also sections C and D). In addition, transversal
sections at the middle trunk level displayed reduction of the
paravertebral mass in Sepn12/2 mice (compare N and O to M;
paravertebral muscles are circled with white dashed lines).
(TIFF)
Figure S3 Accumulation of triadic junction proteins
DHPR, RyR1 and Trisk95 in the tubular aggregates of
Sepn12/2 mice muscles. Immunostainings for DHPR (green)
and RyR1 or Trisk 95 (red) on transversal sections of quadriceps
from 14 month-old mice submitted to FST show that the tubular
aggregates present in muscles from Sepn12/2, but not from wild-
type mice, were highly enriched in triadic junction proteins, in
agreement with a SR origin of these structure previously reported
in the literature [36].
(TIF)
Figure S4 Oxyblot analysis of quadriceps and paraver-
tebral muscles of Sepn1+/+ and Sepn12/2 mice before
and after FST. Histograms represent mean values of total
carbonyl optical densities in quadriceps and paravertebral muscles
from 14 month-old Sepn1+/+ and Sepn12/2 mice, subjected or not
to FST. n= 3. # p,0.05 between Sepn1+/+ and Sepn2/2 muscles;
* p,0.05 between basal and FST-stressed muscles.
(TIF)
Table S1 Primers used for qPCR analysis. Primer
sequences are shown in their 59 to 39 orientation.
(DOC)
Movie S1 Forced Swimming Test (FST). Sequence 1).
General overview of the swimming test device. Sequence 2)
Wild-type FST training session. Five month-old wild-type
mice are actively swimming at the second week of FST.
Sequence 3) Sepn12/2 FST training session. Five month-
old Sepn12/2 are actively swimming at the second week of FST
exercise, similarly to wild-types. Sequence 4) Sepn12/2 FST
week 10. While 6 month-old wild-types are still actively
swimming after 10 weeks, Sepn12/2 mice of the same age showed
a marked reduction of motility, accompanied by a global rigidity.
Sequence 5) Sepn12/2 Immediately post-FST, week 10.
Once taken out of the water, 6 month-old Sepn12/2 mice, which
have been practicing FST for 10 weeks, remained stiff with a
global body and limbs rigidity. This rigidity lasted for several
minutes, before the mice recovered their mobility, a behavior that
was not observed in wild-types. Sequence 6) Spontaneous
activity of wild-type mice after 10 weeks FST. Six month-
old wild-type mice that have been subjected to FST for 10 weeks
are shown for comparison with Sequence 7) Sepn12/2
spontaneous activity post 10 weeks FST. Although 6
month-old Sepn12/2 mice subjected to FST for 10 weeks showed
normal mobility, they displayed a clear deformation of the back.
Sequence 8) Comparison between Sepn12/2 and wild-
type, post 14 weeks FST. 14 month-old mutant or wild-type
mice practicing FST for 14 weeks. The mutant mouse can easily
be distinguished, because of the severe kyphosis. Note that despite
the deformation of the back, the SelN-deficient mouse remained
active.
(MOV)
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Data S1 Treadmill running test. The purpose of this
experiment was to analyze the ability of Sepn12/2 mice to adapt
to an exercise-training test compared to wild-type controls.
Training consisted of running on a motorized treadmill (Colombus
Instrument) at 0% gradient at 15 m/min 3 sessions/week for 20
min the first week, 30 min the second week and 40 min the third
week. After a 15 min acclimation period without motion, the mice
were warmed-up by increasing speed from 9 to 15 m/min during
the initial 3 min (acceleration 2 m/min2). Running was stimulated
using electrical shock grids. Transgenic mice adapted as well as the
wild-types and were able to complete the running tests without
developing any characteristic feature. Detection of Protein
Carbonyls. Carbonylated proteins were detected using immu-
noblotting (OxyBlot Protein Oxidation Detection; Invitrogen) as
described previously [47] and a HRP chemiluminescent detection
(Millipore). Muscle protein samples without the derivatization step
were used as negative controls. After scanning with an imaging
densitometer, optical densities (OD) of protein bands were
quantified using the Image J software. Total protein carbonylation
OD in a given sample was calculated by adding OD of individual
carbonylated protein bands.
(DOC)
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